SRDX News and Press, Surmodics Inc. From 04/28/21

Surmodics, Inc. (SRDX) Q2 2021 Earnings Conference Call April 28, 2021, 08:30 AM ET Company Participants Tim Arens - Senior Vice President of Finance and Chief Financial Officer Gary Maharaj - President and Chief Executive Officer Conference Call Participants Brooks O'Neil - Lake Street Capit...

Image source: The Motley Fool. Surmodics Inc (NASDAQ: SRDX) Q2 2021 Earnings Call Apr 28, 2021 , 8:30 a.m. ET Operator Continue reading For further details see: Surmodics Inc (SRDX) Q2 2021 Earnings Call Transcript

The following slide deck was published by Surmodics, Inc. in conjunction with their 2021 Q2 earnings call. For further details see: Surmodics, Inc. 2021 Q2 - Results - Earnings Call Presentation

Surmodics (SRDX): FQ2 Non-GAAP EPS of $0.62 misses by $0.01; GAAP EPS of $0.58 beats by $0.05.Revenue of $35M (+53.4% Y/Y) beats by $2.04M.2021 Guidance: Expects revenue to range from $101 million to $105 million. The Company expects fiscal 2021 diluted GAAP EPS to range from a loss per share...

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced results for its fiscal 2021 second quarter ended March 31, 2021 and provided its financial outlook for its fiscal 2021. Summary of ...

Webcast is Live at 7:30 a.m. (CT) Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that it will host a live webcast of its second quarter fiscal 2021 conference call on W...

Both opportunity and risk assessments can be drawn from looking at the price action in Surmodics (NASDAQ: SRDX).   This is a practice commonly referred to as reading the charts.  The summary data for SRDX below demonstrates this, and there are trading plans that help inve...

When influential investors make decisions to buy and sell securities, they normally want to keep it quiet.  However, if we pay close attention we can see what is going on, and make good decisions.. The Surmodics (NASDAQ: SRDX) report below can help you understand how to do this. Th...

Surmodics (SRDX) announces the successful first uses with patients for two devices within its Sublime Radial Access Platform: the Sublime Radial Access Guide Sheath and Sublime Radial Access .014 RX PTA Dilatation Catheter. Both Sublime products in multiple cases, including a below-the-knee p...

Sublime™ Radial Access .014 RX PTA Dilatation Catheter, Sublime Radial Access Guide Sheath Deliver Outstanding Performance in Initial Physician Evaluations Surmodics, Inc. (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the ...